MMRF
BATRK icon

Michelson Medical Research Foundation’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Michelson Medical Research Foundation’s Portfolio BATRK Stock Details BATRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Hold
45,130
– – 2.16% 17
2026
Q1 		$1.93M Buy
+45,130
New +$1.88M 1.96% 18

Other funds holding BATRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBCM
Broad Bay Capital Management New York $1.07B AUM 90.15% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Michelson Medical Research Foundation's BATRK Position: Q2 2026 in Review

Michelson Medical Research Foundation held its Atlanta Braves Holdings Series B (BATRK) position steady in Q2 2026 at 45,130 shares worth $2.34M. The position accounts for 2.16% of the portfolio, ranked #17.

Michelson Medical Research Foundation first reported a position in BATRK in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold BATRK as of Q2 2026.

  • Michelson Medical Research Foundation held 45,130 shares of Atlanta Braves Holdings Series B worth $2.34M as of Q2 2026.
  • Michelson Medical Research Foundation left its Atlanta Braves Holdings Series B share count unchanged in Q2 2026.
  • Atlanta Braves Holdings Series B made up 2.16% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #17 holding.
  • Michelson Medical Research Foundation first reported a position in Atlanta Braves Holdings Series B in Q1 2026 and has held it in 2 quarters since.
  • 326 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.